Dan E. Arking

Dan E. Arking

Auto-generated profile, based on publicly available information

Dan E. Arking

Johns Hopkins University School of Medicine

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2013 in Molecular Autism
Verified
Journal Article
Open access
PDF file
BABrett S Abrahams
Brett S Abrahams
DADan E Arking
Dan E Arking
DCDaniel Campbell
Daniel Campbell
HMHeather C Mefford
Heather C Mefford
EMEric M Morrow
Eric M Morrow
APAlan Packer
Alan Packer
New technologies enabling genome-wide interrogation have led to a large and rapidly growing number of autism spectrum disorder (ASD) candidate genes. Although encouraging, the volume and complexity of these data make it challenging for scientists, particularly non-geneticists, to comprehensively evaluate available evidence for individual genes. Described here is the Gene Scoring module within SFARI Gene 2.0 (https://gene.sfari.org/autdb/GS_Home.do), a platform developed to enable systematic community driven assessment of genetic evidence for individual genes with regard to ASD.

10 December 2014 in Nature Communications
Verified
Journal Article
Open access
SGSimone Gupta
Simone Gupta
SEShannon E. Ellis
Shannon E. Ellis
FAForam N. Ashar
Foram N. Ashar
AMAnna Moes
Anna Moes
JBJoel S. Bader
Joel S. Bader
DADan E. Arking
Dan E. Arking
Recent studies of genomic variation associated with autism have suggested the existence of extreme heterogeneity. Large-scale transcriptomics should complement these results to identify core molecular pathways underlying autism. Here we report results from a large-scale RNA sequencing effort, utilizing region-matched autism and control brains to identify neuronal and microglial genes robustly dysregulated in autism cortical brain. Remarkably, we note that a gene expression module corresponding to M2-activation states in microglia is negatively correlated with a differentially expressed neuronal module, implicating dysregulated microglial responses in concert with altered neuronal activity-dependent genes in autism brains. These observations provide pathways and candidate genes that highlight the interplay between innate immunity and neuronal activity in the aetiology of autism.

13 June 2020 in Mitochondrion
Verified
Journal Article
Open access
CCChristina A. Castellani
Christina A. Castellani
RLRyan J. Longchamps
Ryan J. Longchamps
JSJing Sun
Jing Sun
EGEliseo Guallar
Eliseo Guallar
DADan E. Arking
Dan E. Arking
Mitochondrial DNA copy number (mtDNA-CN) is a biomarker of mitochondrial function and levels of mtDNA-CN have been reproducibly associated with overall mortality and a number of age-related diseases, including cardiovascular disease, chronic kidney disease, and cancer. Recent advancements in techniques for estimating mtDNA-CN, in particular the use of DNA microarrays and next-generation sequencing data, have led to the comprehensive assessment of mtDNA-CN across these and other diseases and traits. The importance of mtDNA-CN measures to disease and these advancing technologies suggest the potential for mtDNA-CN to be a useful biomarker in the clinic. While the exact mechanism(s) underlying the association of mtDNA-CN with disease remain to be elucidated, we review the existing literature which supports roles for inflammatory dynamics, immune function and alterations to cell signaling as consequences of variation in mtDNA-CN. We propose that future studies should focus on characterizing longitudinal, cell-type and cross-tissue profiles of mtDNA-CN as well as improving methods for measuring mtDNA-CN which will expand the potential for its use as a clinical biomarker.

14 November 2010 in Nature Genetics
Verified
Journal Article
Open access
PDF file
NSNona Sotoodehnia
Nona Sotoodehnia
AIAaron Isaacs
Aaron Isaacs
PBPaul I W de Bakker
Paul I W de Bakker
MDMarcus Dörr
Marcus Dörr
CNChristopher Newton-Cheh
Christopher Newton-Cheh
DADan E Arking
Dan E Arking
Nona Sotoodehnia and colleagues report a meta-analysis of 14 genome-wide association studies for QRS interval, an electrocardiogram measurement of cardiac ventricular conduction. They identify 22 loci associated with QRS duration. The QRS interval, from the beginning of the Q wave to the end of the S wave on an electrocardiogram, reflects ventricular depolarization and conduction time and is a risk factor for mortality, sudden death and heart failure. We performed a genome-wide association meta-analysis in 40,407 individuals of European descent from 14 studies, with further genotyping in 7,170 additional Europeans, and we identified 22 loci associated with QRS duration (P < 5 × 10−8). These loci map in or near genes in pathways with established roles in ventricular conduction such as sodium channels, transcription factors and calcium-handling proteins, but also point to previously unidentified biologic processes, such as kinase inhibitors and genes related to tumorigenesis. We demonstrate that SCN10A, a candidate gene at the most significantly associated locus in this study, is expressed in the mouse ventricular conduction system, and treatment with a selective SCN10A blocker prolongs QRS duration. These findings extend our current knowledge of ventricular depolarization and conduction.

1 November 2017 in JAMA Cardiology
Verified
Journal Article
Open access
PDF file
FAForam N. Ashar
Foram N. Ashar
YZYiyi Zhang
Yiyi Zhang
RLRyan J. Longchamps
Ryan J. Longchamps
JLJohn Lane
John Lane
AMAnna Moes
Anna Moes
DADan E. Arking
Dan E. Arking
Mitochondria play a critical role in energy homeostasis as the primary site of adenosine triphosphate production. Energy regulation is also dependent on proteins translated from genes encoded in mitochondrial DNA (mtDNA), a 16.7-kb circular DNA molecule. Mitochondrial dysfunction, a hallmark of the aging process, disrupts energy homeostasis and is believed to be a core component of several chronic conditions including cardiovascular disease (CVD).1 Mitochondrial dysfunction may also play a critical role in the initiation and progression of atherosclerosis, the primary pathological lesion underlying CVD. Evidence for this hypothesis is derived from both model organisms and human studies. First, in ApoE knockout mouse models of hyperlipidemia, mtDNA damage occurs prior to plaque formation, and there is significant correlation between mtDNA damage and extent of atherosclerosis in ApoE and human aorta specimens.2 Second, a study using polG knockout mice (which results in elevated rates of mtDNA mutations) and bone marrow transplants into ApoE knockout mice demonstrated that circulating cells increased the necrotic core and decreased the fibrous cap, which are key features of plaque instability.3 Finally, in humans, white blood cell (WBC) mtDNA damage has been associated with high-risk atherosclerotic plaques.3

4 December 2014 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
FAForam N. Ashar
Foram N. Ashar
AMAnna Moes
Anna Moes
AMAnn Z. Moore
Ann Z. Moore
MGMegan L. Grove
Megan L. Grove
PCPaulo H. M. Chaves
Paulo H. M. Chaves
DADan E. Arking
Dan E. Arking